1.
Kyrmanidou E, Kemanetzi C, Stavros C, Trakatelli M-G, Patsatsi A, Madia X, et al. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Dermatol Pract Concept [Internet]. 2024 Apr. 30 [cited 2026 Apr. 25];14(2):e2024119. Available from: https://www.dpcj.org/index.php/dpc/article/view/3895